Nonprofit Organization Predicts Gene Therapy to be Most Cost Effective Treatment for Spinal Muscular Atrophy
qimono / Pixabay

Nonprofit Organization Predicts Gene Therapy to be Most Cost Effective Treatment for Spinal Muscular Atrophy

According to a story from physiciansweekly.com, a recent report from the Institute for Clinical and Economic Review (ICER) suggests that, pending more data about overall price and longterm success rates,…

Continue Reading Nonprofit Organization Predicts Gene Therapy to be Most Cost Effective Treatment for Spinal Muscular Atrophy
Possible Treatment for Spinal Muscular Atrophy Gains PRIME Designation From the EMA
Belova59 / Pixabay

Possible Treatment for Spinal Muscular Atrophy Gains PRIME Designation From the EMA

According to a story from pm360online.com, the pharmaceutical company Roche recently announced that its investigational therapy risdiplam has awarded PRIME designation from the European Medicines Agency (EMA). The drug has…

Continue Reading Possible Treatment for Spinal Muscular Atrophy Gains PRIME Designation From the EMA

Experimental Gene Therapy for Type 1 Spinal Muscular Atrophy Gets Priority Review

According to a story from BioPortfolio, the drug developer Novartis recently announced that the US Food and Drug Administration (FDA) has granted the company's investigational gene therapy AVXS-101, also known…

Continue Reading Experimental Gene Therapy for Type 1 Spinal Muscular Atrophy Gets Priority Review
A Woman With Spinal Muscular Atrophy is Fighting for Access to the Therapy That Could Save Her
source: pixabay.com

A Woman With Spinal Muscular Atrophy is Fighting for Access to the Therapy That Could Save Her

According to a story from MarketWatch, Annie Wilson was diagnosed with spinal muscular atrophy when she was only six months old. With no real treatment options available, doctors told her…

Continue Reading A Woman With Spinal Muscular Atrophy is Fighting for Access to the Therapy That Could Save Her

Cure SMA’s Annual SMA Conference

  • Post author:
  • Post category:

The 2018 Annual SMA Conference This conference will bring together researchers, medical experts, scientists, and patient families to build community, learn, collaborate, and network. The conference consists of two parallel…

Continue Reading Cure SMA’s Annual SMA Conference
Spinraza, a New Drug For SMA Patients Might Be Available Sooner Than Later in the UK
Source: Pixabay

Spinraza, a New Drug For SMA Patients Might Be Available Sooner Than Later in the UK

There is new hope for patients and their families suffering from spinal muscular atrophy (SMA) reported AOL UK News. SMA is a physically debilitating and aggressive disease, and now a new…

Continue Reading Spinraza, a New Drug For SMA Patients Might Be Available Sooner Than Later in the UK